期刊文献+

0.03%卢美根和0.5%噻吗心胺在治疗开角型青光眼和高眼压症中的比较 被引量:2

下载PDF
导出
摘要 青光眼治疗的主要目的是降低眼压。防止高眼压导致视神经萎缩以致视力丧失。目前降眼压的药物大多数是通过针对房水循环的不同环节来抑制房水的生成以达到降眼压的目的。近年来出现了一类具有独特的药理学特性的降眼压药物——前列腺素类药物。卢美根(bimatoprost)是其中的新成员。它是前列腺素的合成拟似物。通过对前列腺素F(PGF)起激动作用。可以增强压力敏感和非压力敏感房水流出途径而有效地降低眼压。本文通过对我院青光眼和高眼压患者应用0.03%的卢美根每日1次和0.5%的噻吗心胺每日2次的比较。来确定卢美根的安全性及有效性。
作者 赵军梅 李焱
出处 《中国药物与临床》 CAS 2007年第2期146-147,共2页 Chinese Remedies & Clinics
  • 相关文献

参考文献5

二级参考文献37

  • 1Stamper RL, Lieberman MF. Becker- Shaffer's Diagnosis and Therapy of the Glaucomas 7^th Edition, Science Press, Harcourt Asia PTE. LTD, 2001, 144. 被引量:1
  • 2Duane TD, Jaeger EA. Clinical Ophthalmology Revisd Edition,Harper & Row, Publishers, 1986, Vo13, Aqueous Humor Dynamic. 1 -24. 被引量:1
  • 3Woodward DF, Andrew SW, Burk RM, Garst ME, inventors;Allergan, Inc, assignee. Non - acidic cytopentane heptanoic acid, 2 - cycloalkyl or arylalkyl derivatives as therapeutic agents.US Patent 5352708. Oct 4, 1994. 被引量:1
  • 4Yu M, lves D, Ramesha CS. Synthesis of prostaglandin E2 ethanolamide from anadamide by cyclooxygenase - 2. J Biol Chem, 1997, 272:21181-21186. 被引量:1
  • 5Sharif NA, Kelly CR, Crider JY. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J Ocul Pharmacol Ther, 2002, 18 (4):313-324. 被引量:1
  • 6Woodward DF, Krauss AH - P, Chen J Lai RK0 Spada CS,Burke RM, et al. The Pharmacology of bimatoprost (Lumigan^TM). Surv. Ophthalmol, 2001, (Suppl) 45:337-345. 被引量:1
  • 7Brubaker RF, Schoff EO, Nau CB, Carpenter SP, Chen K,Vandenburgh AM. Effects of AGN 192024, a new ocular hypotenslve agent, on aqueous dynamics. Am J Ophthalmol, 2001,131 (1): 19-24. 被引量:1
  • 8Herndon LW, Asrani SG, Williams GH, Challa P, Lee PP.Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost. Arch Ophthalmol, 2002, 120(6): 847-849. 被引量:1
  • 9BrandtJD, VanDenburgh AM, Chen K, Whitcup SM; Bimatoprost Study Group. Comparison of once - or twlee - daily bimatoprost with-twice - daily timolol in patients with elevated IOP a 3 -month clinical trial. Ophthalmology, 2001, 108 (6): 1023-1031 ; discussion 1032. 被引量:1
  • 10Laibovitz RA, VanDenburgh AM, Felix C, David R, Batoosingh A, Rosenthal A, Cheetham J. Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.Arch Ophthalmol, 2001, 119 (7): 994-1000. 被引量:1

共引文献3

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部